SCHEMBL8489556

SCHEMBL8489556

OB(O)C1=C(c2ccccc2)C2=NC1=CC1=NC(=CC3=NC(=CC4=NC(=C2c2ccccc2)C(c2ccccc2)=C4c2ccccc2)C=C3)C=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27513464 0.86 — —
SCHEMBL7060717 0.85 — —
SCHEMBL27206851 0.83 — —
SCHEMBL27920656 0.83 — —
SCHEMBL27679602 0.83 — —
SCHEMBL29059809 0.82 — —
SCHEMBL28842895 0.82 — —
Boric Acid SCHEMBL28949539 0.81 — —
SCHEMBL28738337 0.80 — —
SCHEMBL513049 0.80 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1999043317-A1 NECROSIS-AFFINE COMPOUNDS AND THE UTILIZATION THEREOF IN ORDER TO PRODUCE PREPARATIONS FOR PHARMACOTHERAPY SCHERING AKTIENGESELLSCHAFT (DE) 1999-09-02 — — WO disclosed
Send feedback